Full text is available at the source.
Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells
Ginsenoside Rg1’s effects on aging in blood vessel muscle cells
AI simplified
Abstract
Ginsenoside Rg1 significantly reduced the proportion of senescent vascular smooth muscle cells (VSMCs) compared to the D-galactose group.
- D-galactose treatment increased the number of senescent VSMCs, as indicated by a rise in b-galactosidase-positive cells.
- Ultrastructural changes in VSMCs were observed after D-galactose treatment.
- The expression of cell cycle regulators p16, p21, and p53 was significantly elevated in the D-galactose group.
- Rg1 treatment led to a significant decrease in senescent VSMCs and reduced levels of p16, p21, and p53 expression.
- Cell cycle arrest in the G0/G1 phase was less pronounced in Rg1-treated cells compared to those treated with D-galactose.
AI simplified